International Survey on Connected Health: Coming Ready or Not!
Connected Health – sometimes referred to as Digital Health – is a potential game-changer for global healthcare.
Not only does it enable patients and consumers to be more actively engaged in their own health, it allows physicians to provide recommendations based on more than an occasional consultation. Already we can see a shift in the patient-provider relationship.
The first Ipsos International Survey on Connected Health – spanning the USA, UK and Japan and multiple stakeholder perspectives – offers a picture of the uptake and use of connected health technologies (see definition).
The inaugural survey also contains an in-depth focus on Type 2 Diabetes across the study markets, including a technology preference segmentation of patients in the USA and UK. Type 2 Diabetes was chosen for its high prevalence and likelihood to be influenced by digital and connected health in the future.
This study will explore:
- The Definition of Connected Health
- About the Research
- The Ipsos International Survey on Connected Health
- Health & Healthcare: Attitudes & Behaviours
- Connected Health: The General Public’s Perspective
- Connected Health: The Physicians' Perspective
- Spotlight: Telemedicine
- Spotlight: Connected Health & Clinical Trials
- Type 2 Diabetes Deep Dive & Segmentation
(INCLUDED IN REPORT 1 ONLY)- The Type 2 Diabetes Patient Perspective
- The Diabetes Patient vs the Physician Perspective:
Similarities and Differences - The Type 2 Diabetes Patient Segmentation
- Additional Analysis Options
Methodology:
- Two independent online surveys, the first among the general public (20-minute survey) and the second among physicians (15-minute survey).
- The general public sample comprised adults aged 18-80 across UK, USA and Japan. Quotas were set by region, age and gender, and the results have been weighted to match national census and other government statistical reference data for categories that were under-represented in responses received from the online survey. The Type 2 Diabetes sample was boosted and re-weighted back to true population proportions at analysis stage.
- “Mirror image” questions asked to general public, Type 2 Diabetes patients and physicians to ascertain degree of similarity/difference in perceptions of connected health.
- Fieldwork conducted in September – November 2015
Choice of countries + patient group
- USA, UK and Japan chosen for their diversity and ability to provide an international picture (US, EU and Asia).
- Type 2 Diabetes chosen due to its high prevalence and likelihood to be influenced by digital and connected health in the future
